NASDAQ · Medical - Instruments & Supplies

Medline Inc. (MDLN) Stock

$36.26 +1.45% NASDAQ: MDLN Healthcare

Valuation

MetricValue
Price$36.26
Market Cap$30.66B
P/E Ratio40.35
P/B Ratio2.57
P/S Ratio0.98
EPS (TTM)$1.14
52-Week High$50.88
52-Week Low$31.49
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE5.45%
ROA1.76%
ROCE4.96%
Gross Margin24.04%
Operating Margin7.04%
Net Margin2.31%
Debt/Equity1.09
Current Ratio4.29

Annual Financials (USD)

Metric2022202320242025
Revenue$21.4B$23.2B$25.5B$28.4B
Operating Profit$870.0M$1.4B$2.2B$2.2B
Net Profit$-25.0M$234.0M$1.2B$1.2B
EPS$-0.03$0.30$1.52$1.43
Op Margin4.1%6.2%8.7%7.8%

Balance Sheet (USD)

Metric2022202320242025
Total Assets—$36.1B$36.0B$38.5B
Total Liabilities—$19.1B$19.5B$19.2B
Cash—$1.6B$250.0M$1.9B
Borrowings$0$16.8B$16.9B$12.6B

Latest News

Medline (MDLN) COO Exit And New Health Deal Put Valuation In Focus Simply Wall St. · Jul 22, 2026 Medline strengthens California distribution network with new 1 million-square-foot facility in Perris PR Newswire · Jul 20, 2026 Is Medline (MDLN) One of the Best Up and Coming Stocks to Invest In Right Now? Insider Monkey · Jul 12, 2026 Medline Reports Prime Vendor Agreement With Allina Health MT Newswires · Jul 8, 2026 Medline announces Prime Vendor agreement with Allina Health PR Newswire · Jul 8, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$187.0M$1.7B$1.8B$1.7B
Investing Cash Flow$-518.0M$-597.0M$-1.9B$-921.0M
Financing Cash Flow$-23.0M$0$-1.5B$-2.0B
Net Cash Flow$0$1.6B$-1.3B$1.7B
Free Cash Flow$-67.0M$1.4B$1.4B$1.3B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.34
EV / EBITDA15.56
FCF Yield6.90%
Quick Ratio2.61
Interest Coverage2.50
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.21%
Institutions Held100.61%
Institutions Float Held100.82%
Institutional HolderSharesReport Date
Carlyle Group Inc.187,083,7132026-03-31
H&f Corporate Investors X, Ltd.86,473,4972026-03-31
FMR, LLC36,556,2012026-03-31
Capital Research Global Investors23,161,6702026-03-31
Invesco Ltd.20,963,6152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHICFAsahi Intecc Co., Ltd. $21.41 +0.00% 29.51 $5.68B 1.31%
ANGOAngioDynamics, Inc. $11.52 +2.58% -17.17 $476.15M 0.00%
BDXBecton, Dickinson and Company $183.75 +0.55% 55.37 $50.63B 2.28%
CNVVFConvaTec Group Plc $2.95 +4.61% 32.81 $5.75B 3.73%
COOThe Cooper Companies, Inc. $54.37 +0.13% 19.29 $10.60B 0.00%

About Medline Inc.

Medline Inc. is led by CEO James Boyle, employs 43,000 people, headquartered in Northfield, US, publicly traded since 2025.

Medline Inc. (MDLN) stock trades at $36.26 with a market capitalization of $30.66B. The stock is valued at a price-to-earnings (P/E) ratio of 40.35, price-to-book of 2.57, price-to-sales of 0.98. Over the past 52 weeks the stock has ranged between $31.49 and $50.88, and currently trades 28.7% below its 52-week high.

On profitability, Medline Inc. generates a return on equity (ROE) of 5.45%, return on capital employed of 4.96%, an operating margin of 7.04%, a net profit margin of 2.31%.

In its most recent fiscal year, Medline Inc. reported annual revenue of $28.4B, net profit of $1.2B, revenue has compounded at 9.9% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of 1.09, a current ratio of 4.29, total assets of $38.5B, $1.9B in cash and equivalents.

MDLN has a beta of -0.41 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides